Portage Biotech is pivoting to focus on a digital asset treasury centered around Toncoin (TON) and will be rebranded as AlphaTON Capital. The firm has allocated $100 million to build this treasury, and they will adopt the ATON ticker on the Nasdaq. Brittany Kaiser, the incoming CEO, believes that investing in TON presents a major opportunity for the mass adoption of decentralized technologies, particularly as TON integrates with Telegram, which boasts over 1 billion monthly active users. Alongside acquiring TON, AlphaTON Capital aims to engage proactively in the TON ecosystem through network validation, staking, and developing businesses involving DeFi and gaming applications. Despite an earlier stock peak, PRTG shares closed slightly down but maintain that the legacy biotech operations will continue alongside this new venture.

Source 🔗